ARTICLE | Company News
Alcon withdraws Retaane MAA
March 4, 2006 1:38 AM UTC
ACL withdrew an MAA for Retaane anecortave acetate to treat subfoveal choroidal neovascularization (CNV) due to wet age-related macular degeneration (AMD) after EMEA said additional data from existing...